CEFTAZIDIME SODIUM - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for ceftazidime sodium and what is the scope of freedom to operate?
Ceftazidime sodium
is the generic ingredient in two branded drugs marketed by Baxter Hlthcare and Pai Holdings Pharm, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.Summary for CEFTAZIDIME SODIUM
| US Patents: | 0 |
| Tradenames: | 2 |
| Applicants: | 2 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 14 |
| Clinical Trials: | 5 |
| Patent Applications: | 56 |
| DailyMed Link: | CEFTAZIDIME SODIUM at DailyMed |
Recent Clinical Trials for CEFTAZIDIME SODIUM
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Arrevus Inc. | Phase 2 |
| Zunyi Medical College | N/A |
| Fundação de Amparo à Pesquisa do Estado de São Paulo | Phase 4 |
Anatomical Therapeutic Chemical (ATC) Classes for CEFTAZIDIME SODIUM
US Patents and Regulatory Information for CEFTAZIDIME SODIUM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pai Holdings Pharm | FORTAZ IN PLASTIC CONTAINER | ceftazidime sodium | INJECTABLE;INJECTION | 050634-001 | Apr 28, 1989 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| Pai Holdings Pharm | FORTAZ IN PLASTIC CONTAINER | ceftazidime sodium | INJECTABLE;INJECTION | 050634-002 | Apr 28, 1989 | DISCN | Yes | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| Baxter Hlthcare | CEFTAZIDIME SODIUM IN PLASTIC CONTAINER | ceftazidime sodium | INJECTABLE;INJECTION | 063221-001 | Apr 29, 1993 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| Baxter Hlthcare | CEFTAZIDIME SODIUM IN PLASTIC CONTAINER | ceftazidime sodium | INJECTABLE;INJECTION | 063221-003 | Apr 29, 1993 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
